Overview

* Sotera Health ( SHC ) Q3 revenue rose 9.1% to $311 mln, beating analyst expectations

* Adjusted EPS for Q3 increased to $0.26, surpassing analyst estimates

* Adjusted EBITDA for Q3 rose 12.2% to $164 mln, exceeding expectations

Outlook

* Sotera Health ( SHC ) raises 2025 Adjusted EBITDA growth range to 6.75%-7.75%

* Company reaffirms 2025 net revenues growth range of 4.5%-6.0%

* Adjusted EPS range for 2025 raised to $0.81-$0.86

* Interest expense range improved to $154 mln-$158 mln for 2025

* Capital expenditures for 2025 revised to $125 mln-$135 mln

Result Drivers

* STERIGENICS PERFORMANCE - Sterigenics reported a 9.8% increase in Q3 revenue, driven by favorable volume and pricing, despite inflationary pressures

* NORDION GROWTH - Nordion's Q3 revenue rose 22.4%, driven by volume and pricing, though foreign exchange rates were a partial offset

* NELSON LABS MARGINS - Nelson Labs faced a 5.0% revenue decline but improved segment income through pricing and lab optimization

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Beat $311.31 $303.60

Revenue mln mln (6

Analysts

)

Q3 Beat $0.26 $0.22 (7

Adjusted Analysts

EPS )

Q3 Net $48.40

Income mln

Q3 Beat $164 mln $155.50

Adjusted mln (6

EBITDA Analysts

)

Q3 Miss $72.93 $92 mln

Pretax mln (5

Profit Analysts

)

Q3 Gross $177.56

Profit mln

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the healthcare facilities & services peer group is "buy"

* Wall Street's median 12-month price target for Sotera Health Co ( SHC ) is $16.85, about 1.4% above its November 3 closing price of $16.61

* The stock recently traded at 19 times the next 12-month earnings vs. a P/E of 14 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)